申请人:GlaxoSmithKline LLC
公开号:US10022442B2
公开(公告)日:2018-07-17
Compounds of formula (I) and salts thereof:
wherein R1 is n-C1-6alkyl or C1-2alkoxyC1-2alkyl-, R2 is halo, OH or C1-3alkyl, m is an integer having a value of 4, 5, 6 or 7, n is an integer having a value of 0, 1, 2 or 3, and p is an integer having a value of 0, 1 or 2, are inducers of human interferon. Compounds which induce human interferon may be useful in the treatment of various disorders, for example the treatment of allergic diseases and other inflammatory conditions, for example allergic rhinitis and asthma, infectious diseases and cancer, and may also be useful as vaccine adjuvants.
式 (I) 化合物及其盐类:
其中 R1 为 n-C1-6 烷基或 C1-2 烷氧基 C1-2 烷基,R2 为卤代、羟基或 C1-3 烷基,m 为数值为 4、5、6 或 7 的整数,n 为数值为 0、1、2 或 3 的整数,p 为数值为 0、1 或 2 的整数。诱导人类干扰素的化合物可用于治疗各种疾病,例如治疗过敏性疾病和其他炎症,如过敏性鼻炎和哮喘、传染性疾病和癌症,还可用作疫苗佐剂。